Company / SG&A per Share
Nuvation Bio Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.45
FY2025
5-year range
$0.32 / $147.28
FY2021-FY2025
Trend
+41.9%
vs FY2024
Sector context
#173 of 210
Health Care
What the data says
Nuvation Bio Inc.'s sg&a per share of $0.45 is lower than 82% of companies in the Health Care sector (FY2025). SG&A per Share returned to growth in FY2025 after 2 years of decline, reaching $0.45.
Based on SEC 10-K filings.
0.45 in FY2025 with a 5-year CAGR of +31.9%.
Improved from $130.36 to $0.45 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -85.5%
- 5-Year CAGR
- +31.9%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 210This company $0.45 Sector average $40.75
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 41.9% year-over-year.
- Ranks #173 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.45 | +41.9% |
| FY2024 | $0.32 | -99.8% |
| FY2023 | $130.36 | -11.5% |
| FY2022 | $147.28 | +20.0% |
| FY2021 | $122.70 | +109208.2% |
| FY2020 | $0.11 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026